Home > Shareholding > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total of Promoter and Promoter Group Shareholding

   Back to ShareHolding Pattern
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

Last 5 Year Total of Promoter and Promoter Group ShareHolding (%) History of GLENMARK PHARMACEUTICALS

Last 8 Quarters
Sep2026Jun2026Mar2026Dec2025Sep2025Jun2025Mar2025Dec2024
46.65 %46.65 %46.65 %46.65 %46.65 %46.65 %46.65 %46.65 %

What is the latest Total of Promoter and Promoter Group Shareholding of GLENMARK PHARMACEUTICALS ?

The latest Total of Promoter and Promoter Group ShareHolding in GLENMARK PHARMACEUTICALS is 46.65 % based on Sep2026 results.
Year Total of Promoter and Promoter Group
Sep202646.65 %
Jun202646.65 %
Mar202646.65 %
Dec202546.65 %
Sep202546.65 %
Jun202546.65 %
Mar202546.65 %
Dec202446.65 %

How is Total of Promoter and Promoter Group Shareholding of GLENMARK PHARMACEUTICALS Trending?

Years Total of Promoter and Promoter Group % Change
Sep2026 46.65 %
0.00
Jun2026 46.65 %
0.00
Mar2026 46.65 %
0.00
Dec2025 46.65 %
0.00
Sep2025 46.65 %
0.00
Jun2025 46.65 %
0.00
Mar2025 46.65 %
0.00
Dec2024 46.65 % -

Compare Total of Promoter and Promoter Group ShareHolding of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,097.3 Cr -4.2% -13.5% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.2%

-13.5%

17%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses